Q4 2024 Holdings
Filed 2025-02-14 | 21 holdings | $100.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Plains GP Holdings LP-Cl(PAGPEUR) | COMM | 72651A207 | $23.4M | 1,272,360 | 23.2% |
| Madrigal Pharmaceuticals(MDGL) | COMM | 558868105 | $13.3M | 43,032 | 13.2% |
| Akero Therapeutics Inc(AKRO) | COMM | 00973Y108 | $9.6M | 343,729 | 9.5% |
| Achieve Life Sciences Inc(ACHV) | COMM | 004468500 | $8.6M | 2,453,092 | 8.6% |
| Applied Therapeutics Inc(APLT) | COMM | 03828A101 | $8.2M | 9,615,420 | 8.2% |
| Phathom Pharmaceuticals I(PHAT) | COMM | 71722W107 | $8.0M | 989,927 | 8.0% |
| Tscan Therapeutics Inc(TCRX) | COMM | 89854M101 | $6.3M | 2,087,139 | 6.3% |
| Avidity Biosciences Inc(RNA) | COMM | 05370A108 | $5.2M | 178,500 | 5.2% |
| Ardelyx Inc(ARDX) | COMM | 039697107 | $4.8M | 950,947 | 4.8% |
| Abeona Therapeutics Inc(ABEO) | COMM | 00289Y206 | $3.5M | 624,022 | 3.5% |
| Syndax Pharmaceuticals in(SNDX) | COMM | 87164F105 | $2.4M | 183,259 | 2.4% |
| Kymera Therapeutics Inc(KYMR) | COMM | 501575104 | $2.3M | 56,359 | 2.3% |
| Zevra Therapeutics Inc(ZVRA) | COMM | 488445206 | $1.5M | 179,874 | 1.5% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $1.1M | 130,000 | 1.1% |
| Athira Pharma Inc | COMM | 04746L104 | $875.8K | 1,492,792 | 0.9% |
| Eiger Biopharmaceuticals(72C) | COMM | 28249U204 | $765.0K | 146,381 | 0.8% |
| Jasper Therapeutics Inc(JSPR) | COMM | 471871202 | $427.6K | 20,000 | 0.4% |
| Delcath Systems Inc(DCTH) | COMM | 24661P807 | $204.7K | 17,000 | 0.2% |
| Compass Pathways PLC(CMPS) | COMM | 20451W101 | $95.3K | 25,209 | 0.1% |
| Maat Pharma Saca | COMM | F5888J116 | $25.1K | 3,151 | 0.0% |
| Chinook Therapeutics(KDNY) | COMM | 169CVR016 | $9.8K | 79,357 | 0.0% |